China is the bigger Decentralized Clinical Trials(DCTs) market: $132 Mn against $30 Mn in 2023, about 4.4 times as large.
India grows faster: 17.8% a year, against 16.3%. The gap still grows from $102 Mn to $443 Mn by 2033.
Clinical research: 617 active trials in China, 33 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $132 Mn | $30 Mn |
| Market size, 2033 projected | $597 Mn | $154 Mn |
| Growth a year (CAGR) | 16.3% | 17.8% |
| Money added, 2023–2033 | $465 Mn | $124 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.09 | $0.02 |
| Active clinical trials | 617 | 33 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Decentralized Clinical Trials(DCTs), China or India?
China is the bigger Decentralized Clinical Trials(DCTs) market: $132 Mn against $30 Mn in 2023, about 4.4 times as large.
Which grows faster in Decentralized Clinical Trials(DCTs), China or India?
India grows faster: 17.8% a year, against 16.3%. The gap still grows from $102 Mn to $443 Mn by 2033.
More Decentralized Clinical Trials(DCTs) comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.